GlassScriptPhysician profile
Arthur Kwok
NPI 1265954861
$579.11
in general payments reported to CMS, 2019-2025
10 companies · $91.30 in 2025
The $91.30 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.74 · 2022: $16.83 · 2023: $342 · 2024: $116 · 2025: $91.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $123.56 | 2023 | Farxiga |
| Abbvie INC. | $121.81 | 2023 | |
| Merck Sharp & Dohme LLC | $91.07 | 2024-2025 | Zerbaxa, Dificid, Recarbrio |
| Pfizer INC. | $76.28 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $59.18 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.46 | 2022-2024 | Lifevest |
| Philips North America LLC | $18.88 | 2023 | |
| Exact Sciences Corporation | $18.49 | 2025 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $17.79 | 2023 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $16.59 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Kwok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.